These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30017342)

  • 1. Etiology of increased cancer incidence after solid organ transplantation.
    Acuna SA
    Transplant Rev (Orlando); 2018 Oct; 32(4):218-224. PubMed ID: 30017342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
    Gutierrez-Dalmau A; Campistol JM
    Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
    Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
    Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.
    Kitahara CM; Yanik EL; Ladenson PW; Hernandez BY; Lynch CF; Pawlish KS; Engels EA
    Am J Transplant; 2017 Nov; 17(11):2911-2921. PubMed ID: 28397388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis.
    Jin F; Vajdic CM; Poynten IM; McGee-Avila JK; Castle PE; Grulich AE
    Lancet Oncol; 2024 Jul; 25(7):933-944. PubMed ID: 38936380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group.
    O'Neill JP; Sexton DJ; O'Leary E; O'Kelly P; Murray S; Deady S; Daly F; Williams Y; Dean B; Fitzgerald C; Murad A; Mansoor N; O'Neill JO; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Little D; Moloney FJ; Conlon PJ
    Clin Transplant; 2019 Oct; 33(10):e13669. PubMed ID: 31310037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence and risk factors after solid organ transplantation.
    Vajdic CM; van Leeuwen MT
    Int J Cancer; 2009 Oct; 125(8):1747-54. PubMed ID: 19444916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of solid tumours in organ-transplant recipients.
    Ajithkumar TV; Parkinson CA; Butler A; Hatcher HM
    Lancet Oncol; 2007 Oct; 8(10):921-32. PubMed ID: 17913661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P;
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of new-onset diabetes mellitus and association with mortality in childhood solid organ transplant recipients: a population-based study.
    Chanchlani R; Kim SJ; Dixon SN; Jassal V; Banh T; Borges K; Vasilevska-Ristovska J; Paterson JM; Ng V; Dipchand A; Solomon M; Hebert D; Parekh RS
    Nephrol Dial Transplant; 2019 Mar; 34(3):524-531. PubMed ID: 30060206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.
    Grulich AE; van Leeuwen MT; Falster MO; Vajdic CM
    Lancet; 2007 Jul; 370(9581):59-67. PubMed ID: 17617273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients.
    Krisl JC; Doan VP
    Am J Transplant; 2017 Aug; 17(8):1974-1991. PubMed ID: 28394486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of cancer risk in the long-term solid-organ transplant recipient.
    Sherston SN; Carroll RP; Harden PN; Wood KJ
    Transplantation; 2014 Mar; 97(6):605-11. PubMed ID: 24202142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.
    Acuna SA; Fernandes KA; Daly C; Hicks LK; Sutradhar R; Kim SJ; Baxter NN
    JAMA Oncol; 2016 Apr; 2(4):463-9. PubMed ID: 26746479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant Malignancy.
    Rossi AP; Klein CL
    Surg Clin North Am; 2019 Feb; 99(1):49-64. PubMed ID: 30471741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors.
    Piselli P; Verdirosi D; Cimaglia C; Busnach G; Fratino L; Ettorre GM; De Paoli P; Citterio F; Serraino D
    Best Pract Res Clin Obstet Gynaecol; 2014 Nov; 28(8):1251-65. PubMed ID: 25209964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
    Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
    Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts and best practices for management of pre- and post-transplantation cancer.
    Campistol JM; Cuervas-Mons V; Manito N; Almenar L; Arias M; Casafont F; Del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Román A; Serón D; Ussetti P;
    Transplant Rev (Orlando); 2012 Oct; 26(4):261-79. PubMed ID: 22902168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and treatment of cancer in transplant recipients.
    Flattery MP
    J Transpl Coord; 1998 Jun; 8(2):105-10; quiz 111-2. PubMed ID: 9727104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.